Needle-Free
Intradermal
Oncology
Infectious Disease
Global Impact
Resources
Press Coverage
News Releases
Publications
FAQs
Our Blogs
Events
Presentations
About
About Pharmajet
Partner With Us
Contact
Publications
All Categories
Clinical Studies (36)
Pre-Clinical Studies (23)
All Tags
Adjuvants (1)
ANDV (3)
Arboviruses (10)
Atherosclerosis (1)
Cancer (3)
Clinical (2)
COVID-19 (10)
Cow (3)
Dengue (5)
DNA (24)
DOBV (1)
Equine Influenza (1)
Hamster (2)
Hantaviruses (5)
Hepatitis B (1)
HIV (1)
HNTV (1)
Horse (1)
HPV (1)
HTNV (1)
Improved Performance (14)
Inactivated (14)
Infectious Diseases (1)
Influenza (5)
Live Attenuated (7)
Lymphoma (1)
Mice (1)
MMR (3)
Mouse (2)
mRNA (2)
Nanoparticle (1)
Non-Human (1)
Non-Human Primate (10)
Other Applications (2)
Other Viruses (9)
Pentavalent (1)
Phase 1 (6)
Phase 1/2 (3)
Phase 1b (1)
Phase 2 (2)
Phase 2/3 (1)
Phase 3 (2)
Phase 3/4 (1)
Phase 4 (3)
Pig (5)
Polio (14)
Pox (3)
Protein Subunit (2)
PRRSV (1)
PUUV (2)
Rabbit (4)
Rabies (3)
Respiratory Viruses (12)
RNA (3)
SEOV (1)
SNV (2)
Stratis (27)
Tropis (38)
Tropis/Stratis (7)
VEEV (2)
Zika (6)
Reset
Feasibility of jet injector use during inactivated poliovirus vaccine house-to-house vaccination campaigns
2018
Farag, NH
Tags:
Inactivated
,
Polio
,
Stratis
View
A phase 1 study of safety and immunogenicity following intradermal administration of a tetravalent dengue vaccine candidate
2018
Jackson, LA
Tags:
Arboviruses
,
Dengue
,
Live Attenuated
,
Phase 1b
,
Tropis
View
Immunogenicity and safety of measles-mumps-rubella vaccine delivered by disposable-syringe jet injector in India: A randomized, parallel group, non-inferiority trial
2018
Bavdekar, A
Tags:
Live Attenuated
,
MMR
,
Other Viruses
,
Phase 4
,
Stratis
View
Phase I study of an active immunotherapy for asymptomatic phase Lymphoplasmacytic lymphoma with DNA vaccines encoding antigen-chemokine fusion: study protocol
2018
Thomas, SK
Tags:
Cancer
,
DNA
,
Lymphoma
,
Phase 1
,
Tropis
View
Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials
2018
Gaudinski, MR
Tags:
Arboviruses
,
DNA
,
Improved Performance
,
Phase 1
,
Stratis
View
Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial
2017
Alberer, M
Tags:
Improved Performance
,
Other Viruses
,
Phase 1
,
Rabies
,
RNA
,
Stratis
,
Tropis
,
Tropis/Stratis
View
Feasibility of conducting intradermal vaccination campaign with inactivated poliovirus vaccine using Tropis intradermal needle free injection system, Karachi, Pakistan
2017
Yousafzai, MT
Tags:
Inactivated
,
Polio
,
Tropis
View
Safety and immunogenicity of a modified vaccinia Ankara vaccine using three immunization schedules and two modes of delivery: A randomized clinical non-inferiority trial
2017
Jackson, LA
Tags:
Live Attenuated
,
Other Viruses
,
Phase 2
,
Pox
,
Stratis
View
Antigen Targeting to Human HLA Class II Molecules Increases Efficacy of DNA Vaccination
2016
Grodeland, G
Tags:
DNA
,
Improved Performance
,
Influenza
,
Pig
,
Respiratory Viruses
,
Tropis
View
Rapid development of a DNA vaccine for Zika virus
2016
Dowd, K
Tags:
Arboviruses
,
DNA
,
Non-Human Primate
,
Stratis
,
Zika
View
Safety and immunogenicity of inactivated poliovirus vaccine when given with measles–rubella combined vaccine and yellow fever vaccine and when given via different administration routes: a phase 4, randomised, non-inferiority trial in The Gambia
2016
Clarke, E
Tags:
Inactivated
,
Phase 1/2
,
Polio
,
Stratis
,
Tropis
,
Tropis/Stratis
View
Early Transcriptional Signatures of the Immune Response to a Live Attenuated Tetravalent Dengue Vaccine Candidate in Non-human Primates
2016
Strouts, FR
Tags:
Arboviruses
,
Dengue
,
Live Attenuated
,
Non-Human Primate
,
Stratis
,
Tropis
,
Tropis/Stratis
View
«
1
2
3
4
5
»
Menu